Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 1
2014 2
2017 1
2018 3
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Hymenoptera Anaphylaxis as a Clonal Mast Cell Disorder.
Bonadonna P, Scaffidi L. Bonadonna P, et al. Immunol Allergy Clin North Am. 2018 Aug;38(3):455-468. doi: 10.1016/j.iac.2018.04.010. Epub 2018 Jun 9. Immunol Allergy Clin North Am. 2018. PMID: 30007463 Review.
Drug allergy in mast cell disease.
Brockow K, Bonadonna P. Brockow K, et al. Curr Opin Allergy Clin Immunol. 2012 Aug;12(4):354-60. doi: 10.1097/ACI.0b013e328355b7cb. Curr Opin Allergy Clin Immunol. 2012. PMID: 22744266 Review.
PURPOSE OF REVIEW: Mastocytosis in adults is associated with a history of anaphylaxis in 22-49%. In addition, monoclonal mast cell activation syndrome has been described presenting with anaphylaxis, especially in patients with hymenoptera venom …
PURPOSE OF REVIEW: Mastocytosis in adults is associated with a history of anaphylaxis in 22-49%. In addition, monoclonal mast …
A distinct biomolecular profile identifies monoclonal mast cell disorders in patients with idiopathic anaphylaxis.
Carter MC, Desai A, Komarow HD, Bai Y, Clayton ST, Clark AS, Ruiz-Esteves KN, Long LM, Cantave D, Wilson TM, Scott LM, Simakova O, Jung MY, Hahn J, Maric I, Metcalfe DD. Carter MC, et al. J Allergy Clin Immunol. 2018 Jan;141(1):180-188.e3. doi: 10.1016/j.jaci.2017.05.036. Epub 2017 Jun 16. J Allergy Clin Immunol. 2018. PMID: 28629749 Free PMC article. Clinical Trial.
ASqPCR for the KIT D816V mutation was a useful adjunct in helping identify those with systemic mastocytosis but not monoclonal mast cell activation syndrome. A modified overall clonal prediction model was developed by using clinical findi …
ASqPCR for the KIT D816V mutation was a useful adjunct in helping identify those with systemic mastocytosis but not monoclonal mas …
The presence of mast cell clonality in patients with unexplained anaphylaxis.
Gülen T, Hägglund H, Sander B, Dahlén B, Nilsson G. Gülen T, et al. Clin Exp Allergy. 2014 Sep;44(9):1179-87. doi: 10.1111/cea.12369. Clin Exp Allergy. 2014. PMID: 25039926
Onset of episodes is unpredictable and often recurrent. The substantial overlap between the clinical manifestations of UEA and clonal mast cell disorders (CMD) suggests an association between these rare disorders. The two forms of CMD characterized to date are systemic mas …
Onset of episodes is unpredictable and often recurrent. The substantial overlap between the clinical manifestations of UEA and clonal …
Venom immunotherapy in patients with clonal mast cell disorders: IgG4 correlates with protection.
Jarkvist J, Salehi C, Akin C, Gülen T. Jarkvist J, et al. Allergy. 2020 Jan;75(1):169-177. doi: 10.1111/all.13980. Epub 2019 Aug 12. Allergy. 2020. PMID: 31306487 Free article.
BACKGROUND: Patients with clonal mast cell disorders (cMCD), systemic mastocytosis (SM) and monoclonal mast cell activation syndrome (MMAS), represent an increased risk for Hymenoptera venom anaphylaxis (HVA). ...
BACKGROUND: Patients with clonal mast cell disorders (cMCD), systemic mastocytosis (SM) and monoclonal mast cell act …